SEQIRUS Trademark

Trademark Overview


On Monday, August 17, 2015, a trademark application was filed for SEQIRUS with the United States Patent and Trademark Office. The USPTO has given the SEQIRUS trademark a serial number of 86727032. The federal status of this trademark filing is PARTIAL SECTION 8 & 15 ACCEPTED AND ACKNOWLEDGED as of Tuesday, April 16, 2024. This trademark is owned by Seqirus UK Limited. The SEQIRUS trademark is filed in the Chemical Products, Pharmaceutical Products, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical preparations and substances for the [ treatment and ] prevention of [ blood disorders, bleeding disorders, and ] diseases caused by [ bacteria and ] viruses; vaccines; [ blood products, namely, immunoglobulins for medical or clinical use; medicated serums for the treatment of influenza; anti-virals; ] influenza vaccines; adjuvants and antigens for medical purposes; [ blood products, namely, blood plasma, reagent blood cells; products derived from blood and products derived from recombinant DNA technology, namely, immunoglobulins, human albumin, blood clotting factors, plasma volume expanders, blood proteins for therapeutic use; serums, namely, anti-venoms; medicated serums for the treatment of blood disorders and bleeding disorders; test kits, namely, invitro diagnostic reagent test kits for use in detecting cell mediated immune response; pharmaceutical preparations and substances, namely, Rheysys Factor D Antigen reagents for the detection of specific antigens or in blo...

[ Chemical and biological reagents for scientific and non-medical purposes; cell cultures and media for laboratory, scientific and research use; test kits for scientific and non-medical laboratory use for anti-body screening, blood grouping or detection of specific blood cells, antigens and immunoglobulin subtypes; chemical preparations for scientific and industrial purposes; diagnostic and testing agents for scientific and non-medical purposes; Chemical and biological reagents for non-medical purposes; chemical and biological reagents for industrial use for anti-body screening, blood grouping, and for the typing and detection of specific blood cells, determining the presence of antigens on blood cells, and the detection of relevant complement compounds and immunoglobulin subtypes; chemical test kits for the detection of specific blood cells, determining the presence of antigens on blood cells, and the detection of relevant complement compounds and immunoglobulin subtypes for laborator...

[ Medical services; ] medical information services; [ health care services; health care information services, namely, internet-based health care information services; providing medical information concerning blood products; ] providing medical information concerning vaccines [, anti-venoms and immunohematology products, namely, diagnostic reagents; patient support services, namely, providing an Internet-based database of patient medical information, where patients can enquire about medical issues and procedures from other patients and can relay information about their medical experiences for support and community ]
seqirus

General Information


Serial Number86727032
Word MarkSEQIRUS
Filing DateMonday, August 17, 2015
Status705 - PARTIAL SECTION 8 & 15 ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, April 16, 2024
Registration Number5184313
Registration DateTuesday, April 18, 2017
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 13, 2016

Trademark Statements


Description of MarkThe mark consists of stylized wording "SEQIRUS" with a curved line over the letter "S" under another curved line which spans from over the letter "S" to over the letter "E".
Goods and ServicesPharmaceutical preparations and substances for the [ treatment and ] prevention of [ blood disorders, bleeding disorders, and ] diseases caused by [ bacteria and ] viruses; vaccines; [ blood products, namely, immunoglobulins for medical or clinical use; medicated serums for the treatment of influenza; anti-virals; ] influenza vaccines; adjuvants and antigens for medical purposes; [ blood products, namely, blood plasma, reagent blood cells; products derived from blood and products derived from recombinant DNA technology, namely, immunoglobulins, human albumin, blood clotting factors, plasma volume expanders, blood proteins for therapeutic use; serums, namely, anti-venoms; medicated serums for the treatment of blood disorders and bleeding disorders; test kits, namely, invitro diagnostic reagent test kits for use in detecting cell mediated immune response; pharmaceutical preparations and substances, namely, Rheysys Factor D Antigen reagents for the detection of specific antigens or in blood typing; pharmaceutical preparations, namely, reagent red blood cells used to detect antibodies and Immunoglobulin subtypes; ] pharmaceutical preparations, namely, therapeutic monoclonal and polyclonal antibodies and antibodies for use in the treatment of infectious diseases [ ; pharmaceutical preparations, namely, reagents for medical and clinical use for the typing and detection of specific blood cells, and the detection of relevant compliment components and immunoglobulin subtypes ]
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and Services[ Chemical and biological reagents for scientific and non-medical purposes; cell cultures and media for laboratory, scientific and research use; test kits for scientific and non-medical laboratory use for anti-body screening, blood grouping or detection of specific blood cells, antigens and immunoglobulin subtypes; chemical preparations for scientific and industrial purposes; diagnostic and testing agents for scientific and non-medical purposes; Chemical and biological reagents for non-medical purposes; chemical and biological reagents for industrial use for anti-body screening, blood grouping, and for the typing and detection of specific blood cells, determining the presence of antigens on blood cells, and the detection of relevant complement compounds and immunoglobulin subtypes; chemical test kits for the detection of specific blood cells, determining the presence of antigens on blood cells, and the detection of relevant complement compounds and immunoglobulin subtypes for laboratory or research use; chemical preparations for industrial use for anti-body screening, blood grouping, and the typing and detection of specific blood cells ]
Goods and Services[ Medical services; ] medical information services; [ health care services; health care information services, namely, internet-based health care information services; providing medical information concerning blood products; ] providing medical information concerning vaccines [, anti-venoms and immunohematology products, namely, diagnostic reagents; patient support services, namely, providing an Internet-based database of patient medical information, where patients can enquire about medical issues and procedures from other patients and can relay information about their medical experiences for support and community ]

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status CodeB - Sec. 8 - Class(es) in a Multiple Class registration
Class Status DateTuesday, April 16, 2024
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 20, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, August 20, 2015
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSeqirus UK Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBerkshire SL6 8AA
GB

Party NameSeqirus UK Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressLondon, England EC4V6JA
GB

Party NameSeqirus UK Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLondon, England EC4V6JA
GB

Trademark Events


Event DateEvent Description
Tuesday, December 1, 2015ASSIGNED TO EXAMINER
Thursday, August 20, 2015NEW APPLICATION ENTERED
Thursday, August 20, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 21, 2015NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, December 3, 2015NON-FINAL ACTION WRITTEN
Thursday, December 3, 2015NON-FINAL ACTION E-MAILED
Thursday, December 3, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 2, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 2, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 2, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 3, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 1, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, June 24, 2016NON-FINAL ACTION WRITTEN
Friday, June 24, 2016NON-FINAL ACTION E-MAILED
Friday, June 24, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, July 1, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 18, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 25, 2016ASSIGNED TO LIE
Thursday, September 1, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 1, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 20, 2016NON-FINAL ACTION WRITTEN
Tuesday, September 20, 2016NON-FINAL ACTION E-MAILED
Tuesday, September 20, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, October 24, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 31, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 31, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 3, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 10, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, November 23, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 13, 2016PUBLISHED FOR OPPOSITION
Tuesday, December 13, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 7, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, March 6, 2017TEAS DELETE 1(B) BASIS RECEIVED
Monday, March 6, 2017NOTICE OF ALLOWANCE CANCELLED
Monday, March 13, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 13, 20171(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, April 18, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, December 18, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 18, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, November 25, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, November 25, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 18, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, October 18, 2023TEAS SECTION 8 & 15 RECEIVED
Tuesday, April 16, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, April 16, 2024REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, April 16, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED